image
Healthcare - Biotechnology - NASDAQ - US
$ 24.65
-2.11 %
$ 473 M
Market Cap
-9.36
P/E
BALANCE SHEET
903 M ASSETS
87.41%
38.5 M LIABILITIES
32.48%
865 M EQUITY
90.93%
BALANCE SHEET DECOMPOSITION
Balance Sheet Structure Therapeutics Inc.
image
Current Assets 891 M
Cash & Short-Term Investments 884 M
Receivables 0
Other Current Assets 7.69 M
Non-Current Assets 12.1 M
Long-Term Investments 0
PP&E 7.01 M
Other Non-Current Assets 5.11 M
97.81 %Total Assets$903.3m
Current Liabilities 36 M
Accounts Payable 8.02 M
Short-Term Debt 1.7 M
Other Current Liabilities 26.3 M
Non-Current Liabilities 2.47 M
Long-Term Debt 2.16 M
Other Non-Current Liabilities 302 K
20.85 %4.41 %68.33 %5.62 %Total Liabilities$38.5m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020
ASSETS
Cash & Cash Equivalents 169.5 129.8 90.8 0.1 16.4 K
Short Term Investments 714.0 337.5 64.8 2 K 21.1 K
Receivables 0 0 0 0 0
Inventory 0 0 0 0 0
Other Current Assets 7.7 6.3 2.2 1.9 1.0
Total Current Assets 891.2 473.6 93.1 0.1 38.4 K
PP&E 7.0 8.4 1.3 1.79 K 277
Intangible Assets 0 0 0 0 0
Goodwill 0 0 0 0 0
Long Term Investments 0 0 0 0 0
Other Long Term Assets 5.1 45 K 3.5 111 8
Other Assets 0 0 0 0 0
Total Assets 903.3 482.0 97.8 0.1 38.7 K
LIABILITIES
Accounts Payable 8.0 4.7 6.0 3.5 1.5
Short Term Debt 1.7 1.4 0.5 0.3 0.1
Other Current Liabilities 28.0 18.2 6.3 (3.8) (1.7)
Total Current Liabilities 36.0 24.7 13.0 8.66 K 3.04 K
Long Term Debt 2.2 4.0 0 0.3 0.1
Deferred Tax Income 0 0 0 0 0
Other Liabilities 0.3 0.3 0 (0.1) 74.9 K
Total Liabilities 38.5 29.1 213.0 0.2 61.2 K
EQUITY
Common Stock 17 K 14 K 1 K 0 0
Retained Earnings (329.1) (206.6) (117.0) 64.7 K 22.9 K
Other Accumulative Comprehensive Income/Loss 0.9 0.5 (0.1) (167.0) 0
Total Equity 864.8 453.0 (115.1) 64.7 K 22.5 K
Total Liabilities and Equity 903.3 482.0 97.8 0.1 38.7 K
SHARES OUTSTANDING
Common Shares Outstanding 194.3 146.9 146.4 146.4 146.4